Translate AMICOR contents if you like

Saturday, August 29, 2015

Anti-cancer vaccine

Anti-cancer vaccine uses patient’s own cancer cells to trigger immune responses

August 26, 2015
Cancerous melanoma cells shown with their cell bodies (green) and nuclei (blue) are nestled in tiny hollow lumens within the polymeric cryogel (red) structure. (credits: Thomas Ferrante, Sidi A. Bencherif / Wyss Institute at Harvard University)
A new biologically inspired “injectable cryogel whole-cell cancer vaccine” combines patient-specific harvested cancer cells and immune-stimulating chemicals or biological molecules to help the body attack cancer. It has been developed by scientists atHarvard’s Wyss Institute and Dana-Farber Cancer Institute.
This new approach is simpler and more economical than other cancer cell transplantation therapies, which harvest tumor cells and then genetically engineer them to trigger immune… read more

No comments: